These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2859095)

  • 1. Selective inactivation of opioid receptors in rat hippocampus demonstrates that dynorphin-A and -B may act on mu-receptors in the CA1 region.
    Chavkin C; Henriksen SJ; Siggins GR; Bloom FE
    Brain Res; 1985 Apr; 331(2):366-70. PubMed ID: 2859095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voltage-dependent effects of opioid peptides on hippocampal CA3 pyramidal neurons in vitro.
    Moore SD; Madamba SG; Schweitzer P; Siggins GR
    J Neurosci; 1994 Feb; 14(2):809-20. PubMed ID: 7905518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynorphin selectively augments the M-current in hippocampal CA1 neurons by an opiate receptor mechanism.
    Madamba SG; Schweitzer P; Siggins GR
    J Neurophysiol; 1999 Oct; 82(4):1768-75. PubMed ID: 10515966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid receptor-mediated responses in the dentate gyrus and CA1 region of the rat hippocampus.
    Neumaier JF; Mailheau S; Chavkin C
    J Pharmacol Exp Ther; 1988 Feb; 244(2):564-70. PubMed ID: 2894454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid receptor activity in the dentate region of the rat hippocampus.
    Neumaier JF; Chavkin C
    NIDA Res Monogr; 1986; 75():101-4. PubMed ID: 2893261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kappa-opioids decrease excitatory transmission in the dentate gyrus of the guinea pig hippocampus.
    Wagner JJ; Caudle RM; Chavkin C
    J Neurosci; 1992 Jan; 12(1):132-41. PubMed ID: 1345943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the receptor selectivity of opioid agonists in the guinea-pig ileum and mouse vas deferens by use of beta-funaltrexamine.
    Hayes AG; Sheehan MJ; Tyers MB
    Br J Pharmacol; 1985 Dec; 86(4):899-904. PubMed ID: 3000501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dynorphin A (1-17), dynorphin A (1-13) and D-ala2-D-leu5-enkephalin on the excitability of pyramidal cells in CA1 and CA2 of the rat hippocampus in vitro.
    Vidal C; Maier R; Zieglgänsberger W
    Neuropeptides; 1984 Dec; 5(1-3):237-40. PubMed ID: 6152322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of endogenous opioid peptides in modulation of nocifensive response to formalin.
    Wu HE; Hung KC; Mizoguchi H; Nagase H; Tseng LF
    J Pharmacol Exp Ther; 2002 Feb; 300(2):647-54. PubMed ID: 11805228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippocampal mu-receptors mediate opioid reinforcement in the CA3 region.
    Stevens KE; Shiotsu G; Stein L
    Brain Res; 1991 Apr; 545(1-2):8-16. PubMed ID: 1677606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of brain membranes containing a single type of opioid receptor highly selective for dynorphin.
    James IF; Chavkin C; Goldstein A
    Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7570-4. PubMed ID: 6130527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral effects of opioid peptides selective for mu or delta receptors. II. Locomotor activity in nondependent and morphine-dependent rats.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):997-1003. PubMed ID: 3018231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of opioid receptors on gastric muscle cells by selective receptor protection.
    Grider JR; Makhlouf GM
    Am J Physiol; 1991 Jan; 260(1 Pt 1):G103-7. PubMed ID: 1670978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA; Burks TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid receptor selectivity of dynorphin gene products.
    James IF; Fischli W; Goldstein A
    J Pharmacol Exp Ther; 1984 Jan; 228(1):88-93. PubMed ID: 6141278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential modulation by [D-Pen2, D-Pen5]enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected mu agonists in vivo.
    Sheldon RJ; Nunan L; Porreca F
    J Pharmacol Exp Ther; 1989 May; 249(2):462-9. PubMed ID: 2566676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of hypertension development on rat tail artery responses to opioid peptides.
    Wong SC; Ingenito AJ
    Pharmacology; 1995 Jan; 50(1):40-50. PubMed ID: 7899479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of opioid receptors in the cat carotid body involved in chemosensory depression in vivo.
    Kirby GC; McQueen DS
    Br J Pharmacol; 1986 Aug; 88(4):889-98. PubMed ID: 2874862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological effects of dynorphin peptides on hippocampal pyramidal cells in rat.
    Moises HC; Walker JM
    Eur J Pharmacol; 1985 Jan; 108(1):85-98. PubMed ID: 2858395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.